| dc.creator | Folch J. | |
| dc.creator | Olloquequi J. | |
| dc.creator | Ettcheto M. | |
| dc.creator | Busquets O. | |
| dc.creator | Sánchez-López E. | |
| dc.creator | Cano A. | |
| dc.creator | Espinosa-Jiménez T. | |
| dc.creator | García M.L. | |
| dc.creator | Beas-Zarate C. | |
| dc.creator | Casadesús G. | |
| dc.creator | Bulló M. | |
| dc.creator | Auladell C. | |
| dc.creator | Camins A. | |
| dc.date.accessioned | 2020-09-02T22:17:54Z | |
| dc.date.accessioned | 2022-11-08T20:20:22Z | |
| dc.date.available | 2020-09-02T22:17:54Z | |
| dc.date.available | 2022-11-08T20:20:22Z | |
| dc.date.created | 2020-09-02T22:17:54Z | |
| dc.date.issued | 2019 | |
| dc.identifier | 11, , - | |
| dc.identifier | 16634365 | |
| dc.identifier | https://hdl.handle.net/20.500.12728/4492 | |
| dc.identifier.uri | https://repositorioslatinoamericanos.uchile.cl/handle/2250/5143555 | |
| dc.language | en | |
| dc.publisher | Frontiers Media S.A. | |
| dc.subject | Alzheimer’s disease | |
| dc.subject | insulin resistance | |
| dc.subject | Mediterranean diet | |
| dc.subject | neuroinflammation and neurodegeneration | |
| dc.subject | obesity | |
| dc.subject | type 2 diabetes mellitus | |
| dc.subject | adenosine diphosphate | |
| dc.subject | adenosine triphosphate | |
| dc.subject | amyloid beta protein[25-35] | |
| dc.subject | chlorogenic acid | |
| dc.subject | exendin 4 | |
| dc.subject | guggul | |
| dc.subject | insulin | |
| dc.subject | insulin receptor | |
| dc.subject | inulin | |
| dc.subject | liraglutide | |
| dc.subject | lixisenatide | |
| dc.subject | memantine | |
| dc.subject | metformin | |
| dc.subject | peroxisome proliferator activated receptor gamma agonist | |
| dc.subject | pioglitazone | |
| dc.subject | plant medicinal product | |
| dc.subject | silymarin | |
| dc.subject | somatomedin C receptor | |
| dc.subject | stress activated protein kinase 1 | |
| dc.subject | sulfonylurea derivative | |
| dc.subject | unclassified drug | |
| dc.subject | Alzheimer disease | |
| dc.subject | blood brain barrier | |
| dc.subject | cognition | |
| dc.subject | Curcuma longa | |
| dc.subject | dietary supplement | |
| dc.subject | disease association | |
| dc.subject | energy consumption | |
| dc.subject | enzyme activation | |
| dc.subject | frontal cortex | |
| dc.subject | glia cell | |
| dc.subject | glucose metabolism | |
| dc.subject | glucose utilization | |
| dc.subject | hippocampus | |
| dc.subject | human | |
| dc.subject | hypothalamus | |
| dc.subject | hypothesis | |
| dc.subject | insulin resistance | |
| dc.subject | lipid diet | |
| dc.subject | long term potentiation | |
| dc.subject | Mediterranean diet | |
| dc.subject | mild cognitive impairment | |
| dc.subject | mitochondrial biogenesis | |
| dc.subject | mitochondrion | |
| dc.subject | nerve cell | |
| dc.subject | nerve cell plasticity | |
| dc.subject | neuroprotection | |
| dc.subject | non insulin dependent diabetes mellitus | |
| dc.subject | nonhuman | |
| dc.subject | obesity | |
| dc.subject | obesogenic diet | |
| dc.subject | oxidative stress | |
| dc.subject | protein phosphorylation | |
| dc.subject | protein targeting | |
| dc.subject | Review | |
| dc.subject | risk factor | |
| dc.subject | sugar intake | |
| dc.subject | synaptic transmission | |
| dc.subject | Western diet | |
| dc.title | The Involvement of Peripheral and Brain Insulin Resistance in Late Onset Alzheimer’s Dementia | |
| dc.type | Review | |